600833 Shanghai No.1 Pharmacy
- 11.51
- +0.21+1.86%
Shanghai No.1 Pharmacy News
Shanghai First Pharmaceutical Co., Ltd. 2024 Semi-Annual Operating Data Announcement
Announcement of Resolutions of the 14th Meeting of the 10th Board of Supervisors of Shanghai First Pharmaceutical Co., Ltd.
Shanghai First Pharmaceutical Co., Ltd. risk continuous assessment report on Bailian Group Finance Co., Ltd.
Announcement of Resolutions of the 26th Meeting of the 10th Board of Directors of Shanghai First Pharmaceutical Co., Ltd.
Announcement of Resolution of the 25th (Special) Meeting of the 10th Board of Directors of Shanghai No.1 Pharmacy Co., Ltd.
Legal opinion letter from Zhong Lun (Shanghai) Law Firm of Beijing on the public solicitation of voting rights of shareholders of Shanghai No.1 Pharmacy Co., Ltd. by China Securities Small and Medium Investor Service Center.
Announcement on the convening of Shanghai No.1 Pharmacy Co., Ltd.'s 2023 annual and 2024 first quarter performance explanation meeting.
Announcement by Shanghai No.1 Pharmacy Co., Ltd. regarding receipt of a letter from the China Securities Depository and Clearing Corporation Limited on soliciting voting rights.
Announcement of Shanghai No.1 Pharmacy Co., Ltd. regarding the public solicitation of voting rights by the Small and Medium Investor Service Center Co., Ltd.
Announcement of the Resolution of the 24th (Temporary) Meeting of the Tenth Board of Directors of Shanghai No.1 Pharmacy Co., Ltd.
Announcement of Shanghai No.1 Pharmacy Co., Ltd. on holding the 2023 annual and 2024 first quarter performance briefing
Statement and Commitment of Independent Director Nominee
Statement and Commitment of Independent Director Candidates
Announcement of Resolutions of the 13th Meeting of the 10th Board of Supervisors of Shanghai First Pharmaceutical Co., Ltd.
Shanghai First Pharmaceutical Co., Ltd. operating data announcement for the first quarter of 2024
Announcement of Resolutions of the 23rd Meeting of the 10th Board of Directors of Shanghai First Pharmaceutical Co., Ltd.
Shanghai First Pharmaceutical Co., Ltd. Independent Director Debriefing Report (Tang Songlian)
Lixin Certified Public Accountants (Special General Partnership) on the 2023 Audit Report and Financial Statement of Shanghai First Pharmaceutical Co., Ltd.
Shanghai First Pharmaceutical Co., Ltd. 2023 Environmental, Social and Governance (ESG) and Social Responsibility Report
Shanghai First Pharmaceutical Co., Ltd. Independent Director Debriefing Report (Wang Feng)
Analysis
Price Target
No Data
No Data